Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Blood Medicine Volume 11, 2020 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Case Series

Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome

Mario Ojeda-Uribe1 Department of Hematology and Cellular Therapy Unit, Groupe Hospitalier Region Mulhouse-Sud-Alsace (GHRMSA), Mulhouse68070, FranceCorrespondence[email protected]

https://orcid.org/0000-0001-6881-6055

Valérie Rimelen2 Laboratory of Molecular Biology CHRU Strasbourg, Strasbourg67200, France

Cathérine Marzullo3 Laboratory of Immunology, Groupe Hospitalier Region Mulhouse-Sud-Alsace (GHRMSA), Mulhouse68070, France

Pages 67-72 | Published online: 13 Feb 2020

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Christophe Nicol, Brigitte Pan‐Petesch & Jean‐Christopher Ianotto. (2022) Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations. Haemophilia 28:6, pages 938-949.
Crossref

Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová & Zdeněk Král. (2022) Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy. Onkologie 16:Suppl. B, pages 83-102.
Crossref

María Poza, Rodrigo Íñiguez, Irene Zamanillo, Sara Redondo, Rafael Alonso, Joaquín Martínez-López & Ana Jiménez-Ubieto. (2021) Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia. Therapeutic Advances in Hematology 12, pages 204062072110393.
Crossref

. (2020) Idelalisib. Reactions Weekly 1800:1, pages 164-164.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references